Palisade Bio (PALI) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,289.08% |
| Dec 31, 2025 | 1,626.91% |
| Sep 30, 2025 | -51.39% |
| Jun 30, 2025 | -73.67% |
| Mar 31, 2025 | -47.03% |
| Dec 31, 2024 | -33.78% |
| Sep 30, 2024 | -53.07% |
| Jun 30, 2024 | -37.03% |
| Mar 31, 2024 | -26.79% |
| Dec 31, 2023 | -9.34% |
| Sep 30, 2023 | 13.29% |
| Jun 30, 2023 | 275.21% |
| Mar 31, 2023 | 186.87% |
| Dec 31, 2022 | 69.44% |
| Sep 30, 2022 | 217.09% |
| Jun 30, 2022 | 144.59% |
| Mar 31, 2022 | 123.88% |
| Dec 31, 2021 | 144.36% |
| Sep 30, 2021 | 130.51% |
| Jun 30, 2021 | 19.13% |
| Mar 31, 2021 | -96.14% |
| Dec 31, 2020 | -99.26% |
| Sep 30, 2020 | -282.42% |
| Jun 30, 2020 | -695.02% |
| Mar 31, 2020 | -412.64% |
| Dec 31, 2019 | -237.73% |
| Sep 30, 2019 | 57.23% |
| Jun 30, 2019 | -68.22% |
| Mar 31, 2019 | -50.48% |
| Dec 31, 2018 | -28.96% |
| Sep 30, 2018 | -61.27% |
| Jun 30, 2018 | -19.73% |
| Mar 31, 2018 | -32.44% |
| Dec 31, 2017 | -24.85% |
| Sep 30, 2017 | 405.55% |
| Jun 30, 2017 | 819.65% |
| Mar 31, 2017 | 5,873.55% |
| Dec 31, 2016 | 128.11% |
| Sep 30, 2016 | -142.51% |
| Jun 30, 2016 | -94.25% |
| Mar 31, 2016 | -100.87% |
| Dec 31, 2015 | -71.97% |
| Sep 30, 2015 | -57.41% |
| Jun 30, 2015 | -39.49% |
| Mar 31, 2015 | -28.02% |
| Dec 31, 2014 | 110.49% |
| Sep 30, 2014 | 152.86% |
| Jun 30, 2014 | 444.54% |
| Mar 31, 2014 | 372.38% |
| Dec 31, 2013 | 20.73% |
| Sep 30, 2013 | -9.14% |
| Jun 30, 2013 | 77.32% |
| Mar 31, 2013 | 25.57% |
| Dec 31, 2012 | 320.08% |
| Sep 30, 2012 | 133.15% |
| Jun 30, 2012 | -60.28% |
| Dec 31, 2011 | -78.87% |